These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19725775)

  • 1. Morphology and myofiber composition of skeletal musculature of the forelimb in young and aged wild type and myostatin null mice.
    Elashry MI; Otto A; Matsakas A; El-Morsy SE; Patel K
    Rejuvenation Res; 2009 Aug; 12(4):269-81. PubMed ID: 19725775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse.
    Matsakas A; Macharia R; Otto A; Elashry MI; Mouisel E; Romanello V; Sartori R; Amthor H; Sandri M; Narkar V; Patel K
    Exp Physiol; 2012 Jan; 97(1):125-40. PubMed ID: 22058168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of caloric restriction on the forelimb skeletal muscle fibers of the hypertrophic myostatin null mice.
    Elashry MI; Matsakas A; Wenisch S; Arnhold S; Patel K
    Acta Histochem; 2017 Jun; 119(5):582-591. PubMed ID: 28622884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.
    Girgenrath S; Song K; Whittemore LA
    Muscle Nerve; 2005 Jan; 31(1):34-40. PubMed ID: 15468312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high-fat diet on the morphological properties of the forelimb musculature in hypertrophic myostatin null mice.
    Elashry MI; Eldaey A; Glenske K; Matsakas A; Wenisch S; Arnhold S; Patel K
    J Anat; 2019 Oct; 235(4):825-835. PubMed ID: 31198988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased specific force and power production of muscle fibers from myostatin-deficient mice are associated with a suppression of protein degradation.
    Mendias CL; Kayupov E; Bradley JR; Brooks SV; Claflin DR
    J Appl Physiol (1985); 2011 Jul; 111(1):185-91. PubMed ID: 21565991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged absence of myostatin reduces sarcopenia.
    Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
    J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the compact mutant myostatin allele Mstn (Cmpt-dl1Abc) introgressed into a high growth mouse line on skeletal muscle cellularity.
    Rehfeldt C; Ott G; Gerrard DE; Varga L; Schlote W; Williams JL; Renne U; Bünger L
    J Muscle Res Cell Motil; 2005; 26(2-3):103-12. PubMed ID: 16003464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hindlimb skeletal muscle function in myostatin-deficient mice.
    Gentry BA; Ferreira JA; Phillips CL; Brown M
    Muscle Nerve; 2011 Jan; 43(1):49-57. PubMed ID: 21082689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational signalling, atrogenic and myogenic gene expression during unloading and reloading of skeletal muscle in myostatin-deficient mice.
    Smith HK; Matthews KG; Oldham JM; Jeanplong F; Falconer SJ; Bass JJ; Senna-Salerno M; Bracegirdle JW; McMahon CD
    PLoS One; 2014; 9(4):e94356. PubMed ID: 24718581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-30e is negatively regulated by myostatin in skeletal muscle and is functionally related to fiber-type composition.
    Jia H; Zhao Y; Li T; Zhang Y; Zhu D
    Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):392-399. PubMed ID: 28338991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF1 stimulates greater muscle hypertrophy in the absence of myostatin in male mice.
    Hennebry A; Oldham J; Shavlakadze T; Grounds MD; Sheard P; Fiorotto ML; Falconer S; Smith HK; Berry C; Jeanplong F; Bracegirdle J; Matthews K; Nicholas G; Senna-Salerno M; Watson T; McMahon CD
    J Endocrinol; 2017 Aug; 234(2):187-200. PubMed ID: 28533420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle growth after postdevelopmental myostatin gene knockout.
    Welle S; Bhatt K; Pinkert CA; Tawil R; Thornton CA
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E985-91. PubMed ID: 17148752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered primary and secondary myogenesis in the myostatin-null mouse.
    Matsakas A; Otto A; Elashry MI; Brown SC; Patel K
    Rejuvenation Res; 2010 Dec; 13(6):717-27. PubMed ID: 21204650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscle.
    Salzler RR; Shah D; Doré A; Bauerlein R; Miloscio L; Latres E; Papadopoulos NJ; Olson WC; MacDonald D; Duan X
    Proteomics; 2016 Jul; 16(14):2019-27. PubMed ID: 27214824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation.
    Wang Q; McPherron AC
    J Physiol; 2012 May; 590(9):2151-65. PubMed ID: 22393251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The compact mutation of myostatin causes a glycolytic shift in the phenotype of fast skeletal muscles.
    Baán JA; Kocsis T; Keller-Pintér A; Müller G; Zádor E; Dux L; Mendler L
    J Histochem Cytochem; 2013 Dec; 61(12):889-900. PubMed ID: 23979839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of myostatin in early postnatal mouse masseter and rectus femoris muscles.
    Takada H; Miwa Y; Sato I
    Histol Histopathol; 2015 Nov; 30(11):1353-65. PubMed ID: 25982068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice.
    Collins-Hooper H; Sartori R; Macharia R; Visanuvimol K; Foster K; Matsakas A; Flasskamp H; Ray S; Dash PR; Sandri M; Patel K
    J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1049-59. PubMed ID: 24414825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism.
    Jackson MF; Luong D; Vang DD; Garikipati DK; Stanton JB; Nelson OL; Rodgers BD
    J Endocrinol; 2012 Jun; 213(3):263-75. PubMed ID: 22431133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.